Buprenorphine Extended-Release Injection and Cobal
Determining the interaction of Buprenorphine Extended-Release Injection and Cobal and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: buprenorphine
Brand name: Probuphine, Belbuca, Buprenex, Butrans, Sublocade, Subutex
Synonyms: Buprenorphine (implant), Buprenorphine
Generic Name: cyanocobalamin
Brand name: Cobal 1000, Cobolin-M, Depo-Cobolin, Vitamin B12, B-12 Dots, Nascobal, Vitamin B-12
Synonyms: Cobal 1000
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Buprenorphine Extended-Release Injection-Cobal 1000
- Buprenorphine Extended-Release Injection-Cobicistat
- Buprenorphine Extended-Release Injection-Cobicistat and darunavir
- Buprenorphine Extended-Release Injection-Cobicistat, darunavir, emtricitabine, and tenofovir
- Buprenorphine Extended-Release Injection-Cobicistat, elvitegravir, emtricitabine, and tenofovir
- Buprenorphine Extended-Release Injection-Cobimetinib
- Cobal-Buprenorphine implant
- Cobal-Buprenorphine Injection
- Cobal-Buprenorphine injection - Buprenex
- Cobal-Buprenorphine injection - Sublocade
- Cobal-Buprenorphine Intradermal
- Cobal-Buprenorphine oral/buccal